Clinical Trials Directory

Trials / Completed

CompletedNCT04078958

Effects of Salmon Fishmeal Ex Vivo (FishMeal Ex Vivo)

Health Effects of Salmon Fish Meal - ex Vivo Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
University of Oslo · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

Diabetes contributes significantly to the burden of disease in Norway and cardiovascular disease is the main cause of mortality. Both lean and fatty fish are shown to have beneficial health effects. In addition to omega-3 fatty acids, fish contain potential health-promoting components such as taurine, vitamin D, vitamin B12, iodine, selenium and more unspecified components such as bioactive peptides. With the expected growth in the aquaculture sector, more protein-rich by-products will become available. The overall aim of this project is to investigate physiological and molecular effects of fish protein in the form of salmon fishmeal compared to whey in a human intervention study with regard to carbohydrate- and fat metabolism, endocrine factors and inflammation. The investigators will include healthy subjects to a randomized controlled cross over study. The subjects will receive a single, oral dose of fishmeal or whey. Blood samples are taken before (fasting) and 30 and 60 minutes after intake. The molecular effects of fishmeal and whey are investigated ex vivo. This is done by incubating human cell lines (i.e hepatocytes, adipocytes, epithelial cells) with fasting and postprandial serum from the participants.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSalmon fishmealSalmon fishmeal with high protein content
DIETARY_SUPPLEMENTWheyWhey with high protein content

Timeline

Start date
2019-10-15
Primary completion
2019-11-07
Completion
2019-11-07
First posted
2019-09-06
Last updated
2021-09-28

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04078958. Inclusion in this directory is not an endorsement.